South Africa’s Aspen agrees with J&J to manufacture COVID-19 vaccine candidate

South African pharmaceutical company Aspen Pharmacare said on Monday it had entered into a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate. Aspen said it had agreed to provide capacity required for the manufacture of J&J’s vaccine candidate, which is still undergoing clinical trials, at its Port Elizabeth facility.

Leave a Reply